iPump, Inc.

I was recently contacted by a concerned representative from Medtronic MiniMed.  The representative (whose name I will not use) asked me to pass along the following information for Medtronic pump users who may have recalled infusion sets.  Her post indicates Medtronic was deeply concerned about the safety of their clients and the company caught the problem before any adverse events occurred.  I felt it only fair to allow Medtronic to respond to my previous posts voicing my own concerns, using their own words:

Thank you so much for the conversation today.  I’m enclosing the link you can place on your website to inform folks that Lot 8 Quick-sets have been recalled.  It contains instructions of what to do with them and background information.

One thing to note is that the Lot 8 situation was discovered by Medtronic through an employee with diabetes, and not through any patient adverse events. When that occurred, we assessed the situation as quickly as possible, worked with our medical advisors, changed the manufacturing process, and contacted the FDA about the voluntary recall.  We distributed the recall letters along with a supply of corrected infusion sets so that patients had the products they needed right away, and asked them to return their product (the process for doing so it documented on our website).  We also sent a follow up note from our then-president, Chris O’Connell to customers (we have a new president now and her name is Katie Syzman – she’s the first female president at Medtronic, which is very nice).  From an inside perspective, there was a lot of care and compassion from our employees who worked hard do the right thing and act quickly for our customers.  There were many late nights during the month of July!

The website link for more information about what to do with any recalled infusions sets is http://www.medtronicdiabetes.com/lot8/

One Response to “An Update About Medtronic’s Recalled Infusion Sets”